Graybill Wealth Management’s Amgen AMGN Stock Holding History

Graybill Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10	Closed	-$3.25K	–	83
2025 Q1	$3.25K	Buy	+10	New	+$2.95K	﹤0.01%	179

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Graybill Wealth Management's AMGN Position: Q2 2025 in Review

Graybill Wealth Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 10 shares — an estimated $3.25K sold.

Graybill Wealth Management first reported a position in AMGN in Q1 2025 and held it in 1 quarter. The position peaked at $3.25K in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Graybill Wealth Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
Graybill Wealth Management sold 10 Amgen shares in Q2 2025, an estimated $3.25K.
Graybill Wealth Management first reported a position in Amgen in Q1 2025 and held it in 1 quarter.
Graybill Wealth Management's Amgen position peaked at $3.25K in Q1 2025.
2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Graybill Wealth Management's 13F filing for Q2 2025, filed 31 Jul 2025.